STAMFORD, Conn., Feb. 20, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, February 27, 2020, at 4:30 p.m. ET to report fourth quarter and full year 2019 financial results and provide a corporate update.
Invest In Weed TV
News Highlights
- Silly Mistakes to Avoid When Purchasing Cannabis Equipment July 17, 2020
- Stages of the Cannabis Plant Growth Cycle December 3, 2019
- Future Farm Prepares Maine-Grown Hemp Biomass and Seeds for Processing and Market November 25, 2019
- Auxly Announces Outdoor Cultivation Expansion Through the Launch of Robinsons Outdoor Grow November 18, 2019
- Aleafia Health Outdoor Harvest Yields 10,300 kg of Dried Flower at $0.08 Cost per Gram November 11, 2019
- Future Farm’s Maine Hemp Harvest Nearing Completion October 31, 2019
- Massive Revenues Expected as Hemp, Inc. Updates Shareholders on the First Phase of Processing its Hemp Harvest in Oregon October 25, 2019
- KALY – Kali-Extracts Publishes Photos From Historic First Legal Hemp Harvest October 18, 2019
Leave a Reply